Delphine Vivier

Publications

Article dans une revue (10)

Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy Amaury Herbet,Marie Hautière,Frédéric Jean-Alphonse,Delphine Vivier,Christophe Leboeufet al. British journal of cancer reports, 2025, 3 (1), pp.3. ⟨10.1038/s44276-024-00109-y⟩ Article dans une revue hal-05283402v1
Preoperative PET imaging and fluorescence-guided surgery of human glioblastoma using dual-labeled antibody targeting ET&lt;sub&gt;A&lt;/sub&gt; receptors in a preclinical mouse model: A theranostic approach Marie Hautiere,Delphine Vivier,Paul Dorval,Donovan Pineau,Dimitri Kereselidzeet al. Theranostics, 2024, 14 (16), pp.6268-6280. ⟨10.7150/thno.98163⟩ Article dans une revue hal-05032432v1
Synthesis and Preclinical Fluorescence Imaging of Dually Functionalized Antibody Conjugates Targeting Endothelin Receptor-Positive Tumors Delphine Vivier,Marie Hautière,Donovan Pineau,Pierre-Alix Dancer,Amaury Herbetet al. Bioconjugate Chemistry, 2023, 34 (11), pp.2144-2153. ⟨10.1021/acs.bioconjchem.3c00445⟩ Article dans une revue hal-04547377v1
ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model Marie Hautiere,Delphine Vivier,Donovan Pineau,Caroline Denis,Dimitri Kereselidzeet al. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 (11), pp.3192-3201. ⟨10.1007/s00259-023-06268-3⟩ Article dans une revue hal-04122041v1
Bridge-Clamp Bis(tetrazine)s with [N] 8 π-Stacking Interactions and Azido- s -Aryl Tetrazines: Two Classes of Doubly Clickable Tetrazines Clève D Mboyi,Delphine Vivier,Ahmad Daher,Paul Fleurat-Lessard,Hélène Catteyet al. Angewandte Chemie International Edition, 2020, 59 (3), pp.1149-1154. ⟨10.1002/anie.201911947⟩ Article dans une revue hal-02469034v1
The Impact of FcγRI Binding on Immuno-PET Delphine Vivier,Sai Kiran Sharma,Pierre Adumeau,Cindy Rodriguez,Kimberly Funget al. Journal of Nuclear Medicine, 2019, 60 (8), pp.1174-1182. ⟨10.2967/jnumed.118.223636⟩ Article dans une revue hal-05167630v1
Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging Delphine Vivier,Sai Kiran Sharma,Brian Zeglis Journal of Labelled Compounds and Radiopharmaceuticals, 2018, 61 (9), pp.672-692. ⟨10.1002/jlcr.3628⟩ Article dans une revue hal-05167657v1
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K + Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity Delphine Vivier,Ismail Ben Soussia,Nuno Rodrigues,Stéphane Lolignier,Maïly Devillierset al. Journal of Medicinal Chemistry, 2017, 60 (3), pp.1076-1088. ⟨10.1021/acs.jmedchem.6b01285⟩ Article dans une revue hal-02390407v1
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K+ Channel 1). A Novel Therapeutic Target? Delphine Vivier,Khalil Bennis,Florian Lesage,Sylvie Ducki Journal of Medicinal Chemistry, 2016, 59, pp.5149-5157. ⟨10.1021/acs.jmedchem.5b00671⟩ Article dans une revue hal-01349091v1
Synthesis and structure-activity relationship study of substituted caffeateesters as antinociceptive agents modulating the TREK-1 channel. Nuno Rodrigues,Khalil Bennis,Delphine Vivier,Vanessa Pereira,Franck C. Chatelainet al. European Journal of Medicinal Chemistry, 2014, 75, pp.391-402 Article dans une revue hal-00955551v1

Thèse (1)

Vers de nouveaux antalgiques : optimisation de molécules activatrices des canaux potassiques TREK-1 Delphine Vivier Autre. Université Blaise Pascal - Clermont-Ferrand II, 2014. Français. ⟨NNT : 2014CLF22518⟩ Thèse tel-01162628v1